13544-44-0

Basic information

• Product Name: 2, 4-DICHLORO-5-IODOPYRIMIDINE
• Synonyms: 5-Iodo-2,4-dichloropyrimidine;2,4-Dichloro-5-iodopyrimidine;2,4-Dichloro-5-iodo-1,3-diazine;2,4-Dichloro-5-iodopyriMidine, 95+%;Pyrimidine, 2,4-dichloro-5-iodo-;2,4-Dichloro-5-iodopyrimidine 95%
• CAS NO: 13544-44-0
• Molecular Formula: C₄HCl₂IN₂
• Molecular Weight: 274.87
• EINECS: 1312995-182-4
• Product Categories: Pyrimidine series;pharmacetical;Organohalides;Pyrimidine;Pyrimidines;Halides;Pyrazines, Pyrimidines & Pyridazines;Heterocycle-Pyrimidine series
• Mol File: 13544-44-0.mol
• Article Data: 8

Chemical Properties

• Melting Point: 68.0 to 72.0 °C
• Boiling Point: 310.2 °C at 760 mmHg
• Flash Point: 141.4 °C
• Appearance: /
• Density: 2.255 g/cm³
• Vapor Pressure: 0.00111mmHg at 25°C
• Refractive Index: 1.662
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• Solubility: soluble in Methanol
• PKA: -4.19±0.29(Predicted)
• CAS DataBase Reference: 2, 4-DICHLORO-5-IODOPYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2, 4-DICHLORO-5-IODOPYRIMIDINE(13544-44-0)
• EPA Substance Registry System: 2, 4-DICHLORO-5-IODOPYRIMIDINE(13544-44-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22-37/38-41
• Safety Statements: 26-39
• RIDADR: 2811
• WGK Germany: 3
• HazardClass: 6.1
• PackingGroup: Ⅲ
• Hazardous Substances Data: 13544-44-0(Hazardous Substances Data)

Usage

Chemical Properties

Off-white powder

InChI:InChI=1/C4HCl2IN2/c5-3-2(7)1-8-4(6)9-3/h1H

Upstream product

• 696-07-1 5-iodo-2,4-pyrimidine-diol 
• 696-07-1 5-iodouracil 

Downstream Products

• 749860-50-2 C₁₁H₇ClF₂IN₃ 
• 3932-97-6 2,4-dichloro-5-trifluoromethylpyrimidine 
• 871254-61-4 2,4-dichloro-5-pyrimidinecarboxaldehyde 
• 1439394-87-2 tert-butyl 1-(4-(2-chloro-5-iodopyrimidin-4-ylamino)phenyl)cyclobutylcarbamate 
• 1425044-57-0 (S)-3-(1-((2-chloro-5-iodopyrimidin-4-yl)amino)ethyl)-8-(2-methoxypyrimidin-5-yl)-2-phenylisoquinolin-1(2H)-one 
• 1223498-47-2 4-{[(1R,2R)-2-(benzyloxy)-1-methylpropyl]oxy}-2-chloro-5-iodopyrimidine 
• 1273561-17-3 C₂₀H₂₄ClIN₄O₄ 

Relevant articles and documents

Method for preparing 5-trifluoromethyl uracil

The invention belongs to the field of organic synthesis, and specifically relates to a method for preparing 5-trifluoromethyl uracil. The method comprises the following steps: firstly, carrying out chlorination reaction on 5-iodouracil and phosphorus oxychloride, thus obtaining 2,4-dichloro-5-iodopyrimidine; secondly, carrying out trifluoromethylation reaction on the 2,4-dichloro-5-iodopyrimidineand a trifluoromethylating reagent, thus obtaining 2,4-dichloro-5-trifluoromethylpyrimidine; finally, enabling the 2,4-dichloro-5-trifluoromethylpyrimidine to react with acetic acid, thus obtaining aproduct. According to the method disclosed by the invention, since chlorination reaction, trifluoromethylation reaction and hydrolysis reaction are adopted, a key intermediate-trifluoromethyl uracil of trifluorothymidine is synthesized in high yield, low cost and low pollution.

MONOCYCLIC PYRIMIDINE/PYRIDINE COMPOUNDS AS INHIBITORS OF P97 COMPLEX

Monocyclic pyrimidine and pyridine compounds having a benzyl amine substituent at the 4 position and a 5:6 bicyclic heteroaryl substituent at the 2 position of the pyrimidine or pyridine ring as well as optional aliphatic, functional and/or aromatic components substituted at other positions of the ring are disclosed. These compounds are inhibitors of the AAA proteasome complex containing p97 and are effective medicinal agents for treatment of diseases associated with p97 bioactivity such as cancer.

Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV

The discovery of two classes of heterocyclic dipeptidyl peptidase IV (DPP-4) inhibitors, pyrimidinones and pyrimidinediones, is described. After a single oral dose, these potent, selective, and noncovalent inhibitors provide sustained reduction of plasma DPP-4 activity and lowering of blood glucose in animal models of diabetes. Compounds 13a, 27b, and 27j were selected for development.

Substituted sulphoximines as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising the same, methods of preparing the same and uses of the same

The invention relates to substituted sulphoximines according to the general formula (I): in which A, E, G, X, R1, R2, R3, R4, R5, R6, R7, R8, m, p, q, are given in the

ALKYNYLPYRIMIDINES AS TIE2 KINASE INHIBITORS

The invention relates to alkynylpyrimidines according to the general formula (I) in which A, R1, R2, R3, R4, R5, and R6 are as defined in the claims, to pharmaceutical compositions comprising said alkynylpyrimidines, to methods of preparing said alkynylpyrimidines, as well as to uses thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 and VEGFR2 signalling.

SULFOXIMINE-SUBSTITUTED PYRIMIDINES , THEIR PREPARATION AND USE AS DRUGS

The invention relates to sulfoximine-substituted pyrimidines of the general Formula (I) processes for the preparation thereof and their use as kinase inhibitors for treating for example cancer or inflammation.

Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs

The invention relates to sulfoximine-substituted pyrimidines of the general formula I processes for the preparation thereof and their use as drugs.

Palladium-catalysed heteroannulation with terminal alkynes: A highly regio- and stereoselective synthesis of (Z)-3-aryl(alkyl)idene isoindolin-1- ones

A highly regio- and stereoselective method for the synthesis of (Z)-3- aryl(alkyl)idene isoindolin-1-ones through palladium-copper catalysis is described. 2-Iodobenzamide 1 and its substituted derivatives 2-10 were reacted with terminal alkynes 11-19 in the presence of (PPh3)2PdCl2, CuI, and Et3N in DMF mostly at 80°C for 16 h to yield the 2-alkynyl substituted benzamides 20-38, 40-45, 77 which could then be cyclised with NaOEt in EtOH to the 3-aryl(alkyl)idene isoindolin-1-ones 46-49, 51, 53-55, 57, 59-71, 73 and 75. In certain cases, the isoindolin-1-ones 50, 52, 56 and 58 could be directly obtained by the palladium-catalysed reactions. (C) 2000 Elsevier Science Ltd.